Swedish pharmaceutical company Orexo plans to submit OX219, a treatment for opioid dependency, for FDA approval in the U.S.
According to a company release, Orexo is now “on track” to seek approval following an initial consultation with the regulatory organization, which reviewed the clinical program, pre-clinical documentation and manufacturing and control plans for the drug.
Relmada Raises $3M to Develop LevoCap Painkiller
Pain Specialist Dr. David Cheng Joins Midwest Orthopaedics
Middle Fork Surgery Center Visited by Oregon’s Co-Speaker of the House
Ashland, Ky.-based physician Matthew Lewis, MD, owner of Lewis Family Care, pleaded guilty to receiving and selling misbranded drugs with…
Orthopedics is the highest-paying physician specialty, according to Medscape’s “Physician Compensation Report 2025,” released April 11. Medscape surveyed 7,322 physicians…
California is the state with the most registered nurses in the nation, while Wyoming has the least, according to May…
Comments are closed.